scispace - formally typeset
S

Shimon Pollack

Researcher at Rambam Health Care Campus

Publications -  88
Citations -  5201

Shimon Pollack is an academic researcher from Rambam Health Care Campus. The author has contributed to research in topics: Population & Immune system. The author has an hindex of 28, co-authored 88 publications receiving 5051 citations. Previous affiliations of Shimon Pollack include Technion – Israel Institute of Technology & Rappaport Faculty of Medicine.

Papers
More filters
Journal ArticleDOI

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D Murray, +1489 more
- 14 Oct 2015 - 
TL;DR: No associations with mortality were found with any circulating miRNAs studied and these results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection.
Journal ArticleDOI

Fatal varicella associated with selective natural killer cell deficiency.

TL;DR: A 2-year-old girl with recurrent severe varicella infections had a fatal outcome, and the role of NK cells in controlling herpes viral infection is emphasized.
Journal ArticleDOI

Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease

TL;DR: It is concluded that alterations in secretion of IL-1, IL-6, and TNF-α may be related to the good clinical effect of HBO treatment in CD patients with perianal disease.
Journal ArticleDOI

Cytokine Levels (IL-4, IL-6, IL-8 and TGFβ) as Potential Biomarkers of Systemic Inflammatory Response in Trauma Patients

TL;DR: Serum levels of certain cytokines, measured immediately after initial injury, can be used as potential biomarkers for predicting the development and the degree of severity of the systemic inflammatory response (SIRS) in patients with moderate and severe trauma, found to be reliable markers for the existence of immune reactivity in trauma patients.
Journal ArticleDOI

Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids.

TL;DR: A more aggressive approach is needed, such as short or prolonged courses of oral corticosteroids or cyclosporine, to treatUrticarial patients with limited response to oral antihistamines.